The overall chance of developing schizophrenia is roughly 1 in 300 people worldwide, or about 0.3%. Among adults specifically, the rate is slightly higher at about 1 in 233 (0.43%). Those numbers represent the baseline, but your individual risk can be significantly higher or lower depending on genetics, age, substance use, and environmental factors.
How Genetics Shift the Odds
Family history is the single strongest predictor of schizophrenia risk. If you have a first-degree relative (a parent or sibling) with the condition, your risk jumps to about 10%, roughly ten times the general population rate. Having two or more affected relatives pushes the relative risk even higher, to nearly 15 times the baseline.
Twin studies make the genetic contribution especially clear. Among identical twins, who share virtually all their DNA, if one twin has schizophrenia, the other develops it somewhere between 33% and 65% of the time. That wide range itself is telling: if schizophrenia were purely genetic, the concordance rate would be close to 100%. The gap between 65% and 100% represents the role of environment, life experiences, and random biological variation. Fraternal twins, who share about half their genes on average, have much lower concordance rates, confirming that the genetic component is real but not the whole story.
When Schizophrenia Typically Appears
Schizophrenia is most often diagnosed between the late teens and early thirties. Men tend to develop it earlier, typically in late adolescence through their early twenties. Women generally experience onset later, in their early twenties to early thirties. This doesn’t mean you’re safe once you pass 35. At least 20% to 29% of all schizophrenia cases begin after age 40. Late-onset schizophrenia is more common in women, tends to involve less severe symptoms, and often responds to lower doses of medication.
Before full symptoms appear, most people go through a prodromal phase that can last weeks, months, or even years. During this period, changes are subtle: withdrawal from friends, declining performance at school or work, disrupted sleep, increased anxiety or depression, and difficulty concentrating. Closer to full onset, people may start having unusual thoughts they can partially recognize as odd, brief perceptual disturbances, or disorganized speech patterns. These experiences are typically fleeting at first, lasting minutes rather than hours, and occurring infrequently.
Cannabis Use, Especially in Adolescence
Heavy cannabis use is one of the most well-documented environmental risk factors. Across multiple studies, regular cannabis users have roughly three times the odds of developing schizophrenia or a related psychotic disorder compared to non-users. But the timing matters enormously. Studies focusing specifically on adolescent cannabis use have found dramatically higher risk, with some reporting odds ratios as high as 6.5 to 26.7 depending on how exposure and outcomes were measured. The risk also scales with potency and frequency: higher-THC products used more often carry greater risk.
This doesn’t mean every teenager who uses cannabis will develop schizophrenia. Most won’t. But for someone who already carries genetic vulnerability, adolescent cannabis use appears to act as a powerful trigger during a critical window of brain development.
Urban Living and Prenatal Factors
Growing up in a densely urban environment roughly doubles your risk compared to growing up in a rural area. A large meta-analysis estimated the odds at 2.37 times higher in the most urban settings versus the most rural ones. The exact reasons remain unclear, but candidates include social stress, isolation, pollution exposure, and higher rates of infection.
What happened before you were born also plays a role. Maternal infections during pregnancy, particularly bacterial infections, are associated with a two- to three-fold increase in schizophrenia risk for the child. Specific infections linked to higher risk include toxoplasmosis (a parasite commonly found in undercooked meat and cat litter) and cytomegalovirus, both of which roughly double the risk when the mother is infected during pregnancy. Severe nutritional deficiency during pregnancy and obstetric complications also contribute, though to a lesser degree.
What a Diagnosis Actually Requires
Occasional odd thoughts or perceptual quirks are common in the general population and do not mean you have schizophrenia. A formal diagnosis requires at least two of five categories of symptoms: delusions, hallucinations, disorganized speech, severely disorganized or catatonic behavior, and “negative” symptoms like emotional flatness or loss of motivation. At least one of those two must be delusions, hallucinations, or disorganized speech. These symptoms must persist, in some form, for at least six months, with at least one month of active symptoms. The condition must also cause a noticeable decline in functioning at work, in relationships, or in self-care.
If similar symptoms last less than six months, the diagnosis is schizophreniform disorder rather than schizophrenia. This distinction matters because a significant number of people who experience a single psychotic episode recover fully and never develop chronic illness.
Putting Your Risk in Perspective
For someone with no family history, no heavy cannabis use during adolescence, and no known prenatal complications, the lifetime risk sits close to that baseline of roughly 1 in 300. Each risk factor layers on top. A person with one affected parent starts at about 10%. Add adolescent cannabis use and urban upbringing, and the risk climbs further, though precise combined estimates are difficult to calculate because these factors interact in complex ways.
The flip side of the twin data is perhaps the most important takeaway: even among identical twins of someone with schizophrenia, who carry the highest genetic loading possible, more than a third never develop the condition. Genetics loads the gun, but environment, timing, and factors researchers still don’t fully understand determine whether it fires. Most people, even those with elevated risk, will never develop schizophrenia.